Skip to main content
OpenTrials
Completed

NCT Number: NCT03771755

Ibuprofen IV vs Acetaminophen IV for the Treatment of Pain Following Orthopaedic Low Extremity Surgery

This study aims to evaluate the efficacy of IV Ibuprofen versus IV Acetaminophen in the reduction of pain following orthopedic low extremity procedures

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cipto Mangunkusumo Cental National Hospital

Jakarta, DKI Jakarta, 10430, Indonesia

About this study

Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired prior conducting the study. Patients undergoing orthopedic low extremity surgery were screened. Eligible subjects were then randomized into treatment group (intravenous ibuprofen) and control group (intravenous acetaminophen). In case required, patients from both group will be given Morphine (PCA) 1-2 mg every 5 minutes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Scheduled for Orthopedic Low Extremity Surgery with general anesthesia and anticipated need post operative IV analgesia with anticipated use of >48 hours.
  • Adequate IV access.
  • Anticipated hospital stay>48 hours.
  • Age 18-70 years old with physical status ASA I- III.
  • Patients able to fill informed consent sheet.

Exclusion criteria

  • patients with use of analgesia, muscle relaxants, NSAIDs and sedatives less than 24 hours to study drug administration
  • anemia (active, clinically significant anemia) and/or a history or evidence of asthma or heart failure
  • historical or at higher risk intracerebral bleeding, history of allergy or hypersensitive to NSAID, Ibuprofen, Acetaminophen or opioid
  • pregnant or nursing
  • body weight less than 30 kg
  • any active clinically significant bleeding or have underlying platelet dysfunction and/or receiving full dose anticoagulation therapy
  • GI bleeding that required medical intervention within the previous 6 weeks (unless definitive surgery has been performed)
  • on dialysis or renal dysfunction
  • impaired liver function
  • inability to achieve hemostasis or inability to close surgical incision prior to operating room discharge
  • operative procedure includes organ transplant, pre-and intra- operative procedure utilized for the prevention of pre- or post-operative pain (i.e, epidural or nerve blocks)
  • received anoher investigational drug within the past 30 days
  • known or suspected history of alcohol or drug abuse
  • severe infection and/or inflammatory disease

Treatment and study plan

Ibuprofen

Drug

800 mg IV - Ibuprofen every 6 hours. In case required - followed with Morphine (PCA) 1-2 mg every 5 minutes

Acetaminophen

Drug

1000mg IV Acetaminophen every 6 hours. In case required - followed with Morphine (PCA) 1-2 mg every 5 minutes

Primary outcomes

  1. Pain intensity

    Time frame: 24 hours

    demonstrated by the measurement VAS (Visual Analog Scale) for 24 hrs postoperative.

Sponsors and collaborators

Lead sponsor

Indonesia University

Other

Registry information

Official study title

A Prospective, Randomized, Double-blind Study Assessing the Efficacy of Intravenous (IV) Ibuprofen Versus IV Acetaminophen for the Treatment of Pain Following Orthopaedic Low Extremity Surgery

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Dec 11, 2018
Registry last updated
Aug 20, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.